|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 105.47 USD | +34.22% |
|
+33.83% | +51.19% |
| 05-09 | Semiconductors propel Wall Street despite renewed tensions in the Strait of Hormuz | |
| 05-08 | Social Buzz: Wallstreetbets Stocks Mostly Higher Premarket Friday; Iren, Rocket Lab to Advance | MT |
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
Profitability | |||||||
Return on Assets | -10.86 | -8.55 | -11.52 | -11.16 | -8.15 | ||
Return on Total Capital | -13.08 | -10.16 | -14.2 | -14.88 | -10.06 | ||
Return On Equity % | -28.95 | -19.82 | -29.74 | -40.59 | -18.84 | ||
Return on Common Equity | -44.13 | -19.82 | -29.74 | -40.59 | -18.84 | ||
Margin Analysis | |||||||
Gross Profit Margin % | -3.04 | 9 | 21.02 | 26.63 | 34.43 | ||
SG&A Margin | 92.99 | 41.99 | 45.08 | 30.16 | 27.47 | ||
EBITDA Margin % | -145.7 | -49.68 | -60.83 | -36.08 | -30.83 | ||
EBITA Margin % | -157.8 | -57.61 | -67.38 | -40.74 | -35.04 | ||
EBIT Margin % | -163.14 | -63.88 | -72.74 | -43.51 | -38.03 | ||
Income From Continuing Operations Margin % | -188.51 | -64.43 | -74.64 | -43.6 | -32.94 | ||
Net Income Margin % | -188.51 | -64.43 | -74.64 | -43.6 | -32.94 | ||
Net Avail. For Common Margin % | -188.51 | -64.43 | -74.64 | -43.6 | -32.94 | ||
Normalized Net Income Margin | -124.84 | -39.25 | -46.89 | -27.96 | -23.69 | ||
Levered Free Cash Flow Margin | -75.79 | -40.09 | -32.79 | -3.5 | -44.99 | ||
Unlevered Free Cash Flow Margin | -72.12 | -39.12 | -32.89 | -3.64 | -42.76 | ||
Asset Turnover | |||||||
Asset Turnover | 0.11 | 0.21 | 0.25 | 0.41 | 0.34 | ||
Fixed Assets Turnover | 0.73 | 1.71 | 1.31 | 1.81 | 1.75 | ||
Receivables Turnover (Average Receivables) | 5.87 | 6.76 | 5 | 5.61 | 5.7 | ||
Inventory Turnover (Average Inventory) | 1.73 | 2.74 | 1.93 | 2.82 | 2.84 | ||
Short Term Liquidity | |||||||
Current Ratio | 8.04 | 4.06 | 2.13 | 2.04 | 4.08 | ||
Quick Ratio | 7.37 | 3.19 | 1.37 | 1.56 | 3.41 | ||
Operating Cash Flow to Current Liabilities | -0.75 | -0.65 | -0.44 | -0.14 | -0.49 | ||
Days Sales Outstanding (Average Receivables) | 62.23 | 54.03 | 73.03 | 65.28 | 64.02 | ||
Days Outstanding Inventory (Average Inventory) | 210.7 | 133.24 | 189.07 | 129.75 | 128.33 | ||
Average Days Payable Outstanding | 14.57 | 12.02 | 36.18 | 45.5 | 52.89 | ||
Cash Conversion Cycle (Average Days) | 258.36 | 175.25 | 225.92 | 149.53 | 139.46 | ||
Long Term Solvency | |||||||
Total Debt/Equity | 18.73 | 23.25 | 32.87 | 124.16 | 15.4 | ||
Total Debt / Total Capital | 15.77 | 18.86 | 24.74 | 55.39 | 13.34 | ||
LT Debt/Equity | 17.98 | 22.26 | 28.66 | 119.33 | 14.75 | ||
Long-Term Debt / Total Capital | 15.15 | 18.06 | 21.57 | 53.23 | 12.78 | ||
Total Liabilities / Total Assets | 28.79 | 31.94 | 41.08 | 67.71 | 25.93 | ||
EBIT / Interest Expense | -16.57 | -17.28 | -41.88 | -48 | -8.64 | ||
EBITDA / Interest Expense | -14.25 | -12.79 | -33.34 | -37.33 | -6.47 | ||
(EBITDA - Capex) / Interest Expense | -18.44 | -18.22 | -46.22 | -54.3 | -12.37 | ||
Total Debt / EBITDA | -1.5 | -1.57 | -1.29 | -3.22 | -1.55 | ||
Net Debt / EBITDA | 6.41 | 3.25 | 1 | 0.03 | 4.87 | ||
Total Debt / (EBITDA - Capex) | -1.16 | -1.1 | -0.93 | -2.21 | -0.81 | ||
Net Debt / (EBITDA - Capex) | 4.96 | 2.28 | 0.72 | 0.02 | 2.54 | ||
Growth Over Prior Year | |||||||
Total Revenues, 1 Yr. Growth % | 77.01 | 239.02 | 15.92 | 78.34 | 37.96 | ||
Gross Profit, 1 Yr. Growth % | -83.98 | -1.1K | 170.72 | 125.93 | 78.38 | ||
EBITDA, 1 Yr. Growth % | 103.38 | 14.94 | 41.93 | 5.77 | 17.89 | ||
EBITA, 1 Yr. Growth % | 89.95 | 23.11 | 35.6 | 7.84 | 18.65 | ||
EBIT, 1 Yr. Growth % | 88.28 | 32.07 | 32.01 | 6.68 | 20.57 | ||
Earnings From Cont. Operations, 1 Yr. Growth % | 113.29 | 15.87 | 34.3 | 4.16 | 4.22 | ||
Net Income, 1 Yr. Growth % | 113.29 | 15.87 | 34.3 | 4.16 | 4.22 | ||
Normalized Net Income, 1 Yr. Growth % | 132.32 | 6.15 | 37.02 | 5.72 | 16.91 | ||
Diluted EPS Before Extra, 1 Yr. Growth % | -23.37 | -47.83 | 29.96 | 1.19 | -2.6 | ||
Accounts Receivable, 1 Yr. Growth % | 244.44 | 179.83 | 12.68 | 100.05 | 3.48 | ||
Inventory, 1 Yr. Growth % | 83.29 | 92.63 | 16.88 | 10.4 | 33.03 | ||
Net Property, Plant and Equip., 1 Yr. Growth % | 22.19 | 62.5 | 44.25 | 19.61 | 61.18 | ||
Total Assets, 1 Yr. Growth % | 422.09 | 0.84 | -4.84 | 25.83 | 96.27 | ||
Tangible Book Value, 1 Yr. Growth % | -429.85 | -12.58 | -20.49 | -39.15 | 410.83 | ||
Common Equity, 1 Yr. Growth % | -518.96 | -3.61 | -17.63 | -31.03 | 350.21 | ||
Cash From Operations, 1 Yr. Growth % | 158.64 | 48.4 | -7.2 | -50.55 | 238.56 | ||
Capital Expenditures, 1 Yr. Growth % | 2.3 | 65.03 | 28.99 | 22.64 | 132.94 | ||
Levered Free Cash Flow, 1 Yr. Growth % | 21.61 | 78.1 | -5.18 | -80.96 | 828.33 | ||
Unlevered Free Cash Flow, 1 Yr. Growth % | 15.72 | 82.57 | -2.52 | -80.25 | 1.52K | ||
Compound Annual Growth Rate Over Two Years | |||||||
Total Revenues, 2 Yr. CAGR % | 13.4 | 144.97 | 98.24 | 43.78 | 56.86 | ||
Gross Profit, 2 Yr. CAGR % | 32.64 | 26.77 | 421.13 | 147.31 | 100.75 | ||
EBITDA, 2 Yr. CAGR % | 79.89 | 53.33 | 27.72 | 22.52 | 11.66 | ||
EBITA, 2 Yr. CAGR % | 74.79 | 53.33 | 29.2 | 20.92 | 13.11 | ||
EBIT, 2 Yr. CAGR % | 75.69 | 58.09 | 32.04 | 18.67 | 13.41 | ||
Earnings From Cont. Operations, 2 Yr. CAGR % | 96.58 | 57.21 | 24.75 | 18.28 | 4.19 | ||
Net Income, 2 Yr. CAGR % | 96.58 | 57.21 | 24.75 | 18.28 | 4.19 | ||
Normalized Net Income, 2 Yr. CAGR % | 103.55 | 57.37 | 21.24 | 20.71 | 11.17 | ||
Diluted EPS Before Extra, 2 Yr. CAGR % | -61.58 | -36.77 | -17.66 | 14.68 | -0.72 | ||
Accounts Receivable, 2 Yr. CAGR % | 41.2 | 210.46 | 77.57 | 50.14 | 43.88 | ||
Inventory, 2 Yr. CAGR % | 83.95 | 87.91 | 50.05 | 13.59 | 21.19 | ||
Net Property, Plant and Equip., 2 Yr. CAGR % | 19.44 | 40.91 | 53.11 | 31.36 | 38.85 | ||
Total Assets, 2 Yr. CAGR % | 124.17 | 129.46 | -2.04 | 9.42 | 57.15 | ||
Tangible Book Value, 2 Yr. CAGR % | 123.3 | 69.81 | -16.63 | -30.44 | 76.31 | ||
Common Equity, 2 Yr. CAGR % | 142.75 | 100.95 | -10.9 | -24.63 | 76.21 | ||
Cash From Operations, 2 Yr. CAGR % | 82.29 | 95.91 | 17.35 | -32.26 | 29.39 | ||
Capital Expenditures, 2 Yr. CAGR % | 2.8 | 29.93 | 45.9 | 25.78 | 69.02 | ||
Levered Free Cash Flow, 2 Yr. CAGR % | - | 47.68 | 29.95 | -57.51 | 74.9 | ||
Unlevered Free Cash Flow, 2 Yr. CAGR % | - | 45.88 | 33.4 | -56.12 | 78.84 | ||
Compound Annual Growth Rate Over Three Years | |||||||
Total Revenues, 3 Yr. CAGR % | - | 63.36 | 90.9 | 91.37 | 41.82 | ||
Gross Profit, 3 Yr. CAGR % | - | 160.36 | 63.25 | 294.42 | 121.79 | ||
EBITDA, 3 Yr. CAGR % | - | 55.24 | 49.43 | 19.94 | 20.96 | ||
EBITA, 3 Yr. CAGR % | - | 55.79 | 47.17 | 21.65 | 20.16 | ||
EBIT, 3 Yr. CAGR % | - | 60.02 | 48.87 | 22.98 | 19.3 | ||
Earnings From Cont. Operations, 3 Yr. CAGR % | - | 64.82 | 49.17 | 17.47 | 13.39 | ||
Net Income, 3 Yr. CAGR % | - | 64.82 | 49.17 | 17.47 | 13.39 | ||
Normalized Net Income, 3 Yr. CAGR % | - | 64.07 | 50.8 | 16.05 | 19.43 | ||
Diluted EPS Before Extra, 3 Yr. CAGR % | - | -57.46 | -19.61 | -11.8 | 8.6 | ||
Accounts Receivable, 3 Yr. CAGR % | - | 77.36 | 121.46 | 84.77 | 32.62 | ||
Inventory, 3 Yr. CAGR % | - | 86.8 | 60.4 | 35.46 | 19.74 | ||
Net Property, Plant and Equip., 3 Yr. CAGR % | - | 32.35 | 42.02 | 41.01 | 40.63 | ||
Total Assets, 3 Yr. CAGR % | - | 71.76 | 71.11 | 6.49 | 32.95 | ||
Tangible Book Value, 3 Yr. CAGR % | - | 63.36 | 31.86 | -24.93 | 35.2 | ||
Common Equity, 3 Yr. CAGR % | - | 78.42 | 49.28 | -18.19 | 36.76 | ||
Cash From Operations, 3 Yr. CAGR % | - | 70.21 | 52.72 | -12.02 | 15.82 | ||
Capital Expenditures, 3 Yr. CAGR % | - | 20.37 | 29.62 | 37.7 | 54.46 | ||
Levered Free Cash Flow, 3 Yr. CAGR % | - | - | 27.4 | -31.49 | 47.37 | ||
Unlevered Free Cash Flow, 3 Yr. CAGR % | - | - | 27.53 | -29.43 | 46.08 | ||
Compound Annual Growth Rate Over Five Years | |||||||
Total Revenues, 5 Yr. CAGR % | - | - | - | 55.23 | 76.47 | ||
Gross Profit, 5 Yr. CAGR % | - | - | - | 155.06 | 77.32 | ||
EBITDA, 5 Yr. CAGR % | - | - | - | 41.22 | 32.99 | ||
EBITA, 5 Yr. CAGR % | - | - | - | 40.78 | 32.47 | ||
EBIT, 5 Yr. CAGR % | - | - | - | 41.98 | 33.52 | ||
Earnings From Cont. Operations, 5 Yr. CAGR % | - | - | - | 44.33 | 29.22 | ||
Net Income, 5 Yr. CAGR % | - | - | - | 44.33 | 29.22 | ||
Normalized Net Income, 5 Yr. CAGR % | - | - | - | 45.42 | 33.64 | ||
Diluted EPS Before Extra, 5 Yr. CAGR % | - | - | - | -36.75 | -12.53 | ||
Accounts Receivable, 5 Yr. CAGR % | - | - | - | 65.93 | 86.37 | ||
Inventory, 5 Yr. CAGR % | - | - | - | 53.1 | 43.39 | ||
Net Property, Plant and Equip., 5 Yr. CAGR % | - | - | - | 31.95 | 40.74 | ||
Total Assets, 5 Yr. CAGR % | - | - | - | 43.42 | 65.38 | ||
Tangible Book Value, 5 Yr. CAGR % | - | - | - | 16.1 | 48.11 | ||
Common Equity, 5 Yr. CAGR % | - | - | - | 26.4 | 59.52 | ||
Cash From Operations, 5 Yr. CAGR % | - | - | - | 17.74 | 42.92 | ||
Capital Expenditures, 5 Yr. CAGR % | - | - | - | 22.51 | 44.14 | ||
Levered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 47.49 | ||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | - | - | - | 46 |
- Stock Market
- Equities
- RKLB Stock
- Financials Rocket Lab Corporation
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















